Segundo, Mark S.
HRN: 23-34-50 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/17/2023
AZITHROMYCIN 200MG/5ML, 15ML SUSPENSION (SUSP)
08/17/2023
08/24/2023
ORAL
0.8ml
Q24
Neonatal Pneumonia
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes